{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 0.36854708, "regularMarketPrice": 8.17, "exchange": "FRA", "shortName": "CTI BIOPHARMA CORP.", "longName": "CTI BioPharma Corp.", "messageBoardId": "finmb_26241", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683895219, "regularMarketDayHigh": 8.17, "regularMarketDayRange": "7.95 - 8.17", "regularMarketDayLow": 7.95, "regularMarketVolume": 2386, "regularMarketPreviousClose": 8.14, "bid": 8.19, "ask": 8.286, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 8.13, "averageDailyVolume3Month": 244, "averageDailyVolume10Day": 1133, "fiftyTwoWeekLowChange": 4.466, "fiftyTwoWeekLowChangePercent": 1.2057235, "fiftyTwoWeekRange": "3.704 - 8.17", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "fiftyTwoWeekLow": 3.704, "fiftyTwoWeekHigh": 8.17, "earningsTimestamp": 1683837000, "earningsTimestampStart": 1691438400, "earningsTimestampEnd": 1691784000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.33, "epsForward": -0.54, "sharesOutstanding": 131880000, "bookValue": -0.134, "fiftyDayAverage": 4.45922, "fiftyDayAverageChange": 3.7107801, "fiftyDayAverageChangePercent": 0.83215904, "twoHundredDayAverage": 5.24013, "twoHundredDayAverageChange": 2.9298701, "twoHundredDayAverageChangePercent": 0.55912167, "marketCap": 1078056064, "forwardPE": -15.129629, "priceToBook": -60.97015, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1198825200000, "priceHint": 2, "regularMarketChange": 0.029999733, "symbol": "CEPS.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3101 Western Avenue", "address2": "Suite 800", "city": "Seattle", "state": "WA", "zip": "98121", "country": "United States", "phone": "206 282 7100", "fax": "206 284 6206", "website": "https://www.ctibiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.", "fullTimeEmployees": 127, "companyOfficers": [{"maxAge": 1, "name": "Dr. Adam R. Craig M.B.A., M.D., Ph.D.", "age": 56, "title": "Pres, CEO, Interim Chief Medical Officer & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 1085748, "fmt": "1.09M", "longFmt": "1,085,748"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David H. Kirske", "age": 68, "title": "Exec. VP, CFO & Sec.", "yearBorn": 1954, "fiscalYear": 2022, "totalPay": {"raw": 590410, "fmt": "590.41k", "longFmt": "590,410"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 4234858, "fmt": "4.23M", "longFmt": "4,234,858"}}, {"maxAge": 1, "name": "Mr. James K. Fong", "age": 60, "title": "Exec. VP & Chief Commercial Officer", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 597302, "fmt": "597.3k", "longFmt": "597,302"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 2728601, "fmt": "2.73M", "longFmt": "2,728,601"}}, {"maxAge": 1, "name": "Mr. Ed  Bell", "title": "Sr. Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bruce K. Bennett Jr.", "age": 70, "title": "Sr. VP Global Pharmaceutical Operations", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John P. Volpone", "title": "Exec. VP & Chief of Staff", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jennifer A. Smith", "title": "Sr. VP of Biometrics", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 5, "shareHolderRightsRisk": 1, "overallRisk": 2, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}